Skip to content
10-K

Annual Report

HILLEVAX, INC.

0000950170-25-046924

← back to feed
Filed
Mar 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 10, 2025 50.14M sh
Shares Diluted FY 2024 · Dec 31, 2024 49.15M sh
Shares Diluted FY 2024 · Dec 31, 2023 40.6M sh
Capex FY 2024 · Dec 31, 2024 $522K
Capex FY 2024 · Dec 31, 2023 $10.75M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$108.79M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$86.78M
Cash And Equivalents FY 2024 · Dec 31, 2024 $154.47M
Cash And Equivalents FY 2024 · Dec 31, 2023 $216.68M
Stockholders Equity FY 2024 · Dec 31, 2024 $154.49M
Stockholders Equity FY 2024 · Dec 31, 2023 $265.53M
Stockholders Equity FY 2024 · Dec 31, 2022 $267.23M
Current Liabilities FY 2024 · Dec 31, 2024 $16.46M
Current Liabilities FY 2024 · Dec 31, 2023 $29.27M
Total Liabilities FY 2024 · Dec 31, 2024 $38.2M
Total Liabilities FY 2024 · Dec 31, 2023 $78.91M
Current Assets FY 2024 · Dec 31, 2024 $178.35M
Current Assets FY 2024 · Dec 31, 2023 $310.68M
Total Assets FY 2024 · Dec 31, 2024 $192.69M
Total Assets FY 2024 · Dec 31, 2023 $344.43M
Eps Diluted FY 2024 · Dec 31, 2024 −$3.00
Eps Diluted FY 2024 · Dec 31, 2023 −$3.04
Eps Basic FY 2024 · Dec 31, 2024 −$3.00
Eps Basic FY 2024 · Dec 31, 2023 −$3.04
Sga Expense FY 2024 · Dec 31, 2024 $28.79M
Sga Expense FY 2024 · Dec 31, 2023 $26.66M
Net Income FY 2024 · Dec 31, 2024 −$147.27M
Net Income FY 2024 · Dec 31, 2023 −$123.57M
Operating Income FY 2024 · Dec 31, 2024 −$155.29M
Operating Income FY 2024 · Dec 31, 2023 −$133.35M
Long Term Debt FY 2024 · Dec 31, 2023 $25.24M